Colgate-Palmolive (NYSE:CL – Get Rating) shares were up 0.6% during mid-day trading on Thursday . The company traded as high as $74.57 and last traded at $74.57. Approximately 60,256 shares were traded during trading, a decline of 99% from the average daily volume of 5,371,499 shares. The stock had previously closed at $74.16.
A number of analysts recently weighed in on CL shares. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $90.00 to $88.00 in a research report on Wednesday, April 13th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, April 13th. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $86.00 to $81.00 and set a “neutral” rating on the stock in a report on Wednesday, March 30th. Raymond James initiated coverage on Colgate-Palmolive in a report on Thursday, April 7th. They issued a “market perform” rating on the stock. Finally, Atlantic Securities cut Colgate-Palmolive from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $92.00 to $80.00 in a research report on Tuesday, May 3rd. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $85.40.
The company has a debt-to-equity ratio of 10.42, a current ratio of 1.09 and a quick ratio of 0.67. The business has a 50 day simple moving average of $78.37 and a 200 day simple moving average of $79.13. The company has a market capitalization of $61.88 billion, a price-to-earnings ratio of 30.68, a PEG ratio of 5.18 and a beta of 0.56.
The business also recently declared a quarterly dividend, which will be paid on Monday, August 15th. Investors of record on Thursday, July 21st will be issued a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.55%. The ex-dividend date of this dividend is Wednesday, July 20th. Colgate-Palmolive’s dividend payout ratio is currently 77.69%.
Colgate-Palmolive announced that its Board of Directors has approved a share buyback plan on Thursday, March 10th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to reacquire up to 8.1% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.
In other news, VP Philip G. Shotts sold 10,000 shares of the business’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of $78.52, for a total transaction of $785,200.00. Following the completion of the sale, the vice president now directly owns 46,094 shares of the company’s stock, valued at approximately $3,619,300.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, June 6th. The shares were sold at an average price of $79.34, for a total transaction of $3,967,000.00. Following the transaction, the chief executive officer now owns 221,790 shares in the company, valued at approximately $17,596,818.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 79,683 shares of company stock valued at $6,297,119. 0.31% of the stock is owned by insiders.
Several institutional investors have recently bought and sold shares of the company. Bank of New Hampshire increased its stake in Colgate-Palmolive by 0.5% during the first quarter. Bank of New Hampshire now owns 24,551 shares of the company’s stock valued at $1,862,000 after acquiring an additional 123 shares during the period. Avantax Planning Partners Inc. boosted its position in Colgate-Palmolive by 1.3% during the fourth quarter. Avantax Planning Partners Inc. now owns 9,719 shares of the company’s stock valued at $829,000 after purchasing an additional 129 shares during the last quarter. Meridian Wealth Management LLC lifted its position in shares of Colgate-Palmolive by 3.4% in the fourth quarter. Meridian Wealth Management LLC now owns 3,946 shares of the company’s stock valued at $337,000 after buying an additional 131 shares during the last quarter. Somerset Trust Co lifted its position in shares of Colgate-Palmolive by 0.5% in the fourth quarter. Somerset Trust Co now owns 25,737 shares of the company’s stock valued at $2,196,000 after buying an additional 132 shares during the last quarter. Finally, Mission Wealth Management LP lifted its position in shares of Colgate-Palmolive by 3.0% in the fourth quarter. Mission Wealth Management LP now owns 4,560 shares of the company’s stock valued at $389,000 after buying an additional 134 shares during the last quarter. Institutional investors and hedge funds own 78.12% of the company’s stock.
Colgate-Palmolive Company Profile (NYSE:CL)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- The Q2 Earnings Season Could Be A Bloodbath
- Commercial Metals Company Is Ready To Rebound
- The Institutions Turn The Tide For Jabil
- A10 Networks: Key 5G Infrastructure Stock that’s Beating the Market
- Allstate: A Safe Stock During Volatile Times, Which Will Benefit From Rising Rates
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.